Evidence map›Paper›PMID 24586229›Full record

ArticlePloS one2014

A 3-marker index improves the identification of iron disorders in CKD anaemia.

Lucile Mercadal, Marie Metzger, Jean Philippe Haymann, Eric Thervet, Jean-Jacques Boffa, Martin Flamant, François Vrtovsnik, Cédric Gauci, Marc Froissart, Bénédicte Stengel and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2018
    Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Lucile MercadalInstitut National de la Santé et de la Recherche Médicale U1018, CESP Centre for research in Epidemiology and Population Health, Epidemiology of Diabetes, Obesity, and Kidney Diseases Team, Villejuif, France ; Department of Nephrology, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Marie MetzgerInstitut National de la Santé et de la Recherche Médicale U1018, CESP Centre for research in Epidemiology and Population Health, Epidemiology of Diabetes, Obesity, and Kidney Diseases Team, Villejuif, France ; Univ Paris Sud 11, UMRS 1018, Villejuif, France.
Jean Philippe HaymannDepartment of Physiology and Nephrology, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris, France ; Institut National de la Santé et de la Recherche Médicale U702, Paris, France.
Eric ThervetDepartment of Nephrology, Hôpital Européen G Pompidou, Assistance Publique-hôpitaux de Paris, Université Paris Descartes, Paris, France ; Institut National de la Santé et de la Recherche Médicale UMR S775, Paris, France.
Jean-Jacques BoffaInstitut National de la Santé et de la Recherche Médicale U702, Paris, France ; Department of Nephrology, Hôpital Tenon, Assistance Publique-hôpitaux de Paris, Université Pierre et Marie Curie, Paris, France.
Martin FlamantDepartment of Physiology, Hôpital Bichat, Assistance Publique-hôpitaux de Paris, Paris, France ; Institut National de la Santé et de la Recherche Médicale U699, Université Paris Diderot, Paris, France.
François VrtovsnikInstitut National de la Santé et de la Recherche Médicale U699, Université Paris Diderot, Paris, France ; Department of Nephrology, Hôpital Bichat, Assistance Publique-hôpitaux de Paris, Paris, France.
Cédric GauciDepartment of Physiology, Hôpital Européen G Pompidou, Assistance Publique-hôpitaux de Paris, Université Paris Descartes, Paris, France.
Marc FroissartInstitut National de la Santé et de la Recherche Médicale U1018, CESP Centre for research in Epidemiology and Population Health, Epidemiology of Diabetes, Obesity, and Kidney Diseases Team, Villejuif, France ; Department of Physiology, Hôpital Européen G Pompidou, Assistance Publique-hôpitaux de Paris, Université Paris Descartes, Paris, France.
Bénédicte StengelInstitut National de la Santé et de la Recherche Médicale U1018, CESP Centre for research in Epidemiology and Population Health, Epidemiology of Diabetes, Obesity, and Kidney Diseases Team, Villejuif, France ; Univ Paris Sud 11, UMRS 1018, Villejuif, France.
NephroTest Study Group
Sorbonne Université · FRCentre de recherche en Epidémiologie et Santé des Populations · FRDélégation Paris 5 · FRUniversité Claude Bernard Lyon 1 · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIron disorders are common and complex in chronic kidney disease (CKD). We sought to determine whether a 3-marker index would improve the classification of iron disorders in CKD anaemia.

methodsWe studied the association between Hb level and iron indexes combining 2 or 3 of the following markers: serum ferritin (<40 ng/mL), transferrin saturation (TSAT<20%) and total iron binding capacity (TIBC<50 µmol/L) in 1011 outpatients with non-dialysis CKD participating in the Nephrotest study. All had glomerular filtration rates measured (mGFR) by (51)Cr-EDTA renal clearance; 199 also had hepcidin measures.

resultsThe TSAT-TIBC-ferritin index explained Hb variation better than indexes combining TSAT-TIBC or ferritin-TSAT. It showed hypotransferrinaemia and non-inflammatory functional iron deficiency (ID) to be more common than either absolute or inflammatory ID: 20%, 19%, 6%, and 2%, respectively. Hb was lower in all abnormal, compared with normal, iron profiles, and decreased more when mGFR was below 30 mL/min/1.73 m(2) (interaction p<0.0001). In patients with mGFR<30 mL/min/1.73 m(2), the Hb decreases associated with hypotransferrinaemia, non-inflammatory functional ID, and absolute ID were 0.83±0.16 g/dL, 0.51±0.18 and 0.89±0.29, respectively. Compared with normal iron profiles, hepcidin was severely depressed in absolute ID but higher in hypotransferrinaemia.

conclusionsThe combined TSAT-TIBC-ferritin index identifies hypotransferrinaemia and non-inflammatory functional ID as the major mechanisms of iron disorders in CKD anaemia. Both disorders were associated with a greater decrease in Hb when mGFR was <30 mL/min/1.73 m(2). Taking these iron profiles into account may be useful in stratifying patients in clinical trials of CKD anaemia and might improve the management of iron therapy.

Indexed as

AgedAnemiaBiomarkersFemaleFerritinsGlomerular Filtration RateHemoglobinsHumansIronKidneyMaleMiddle AgedRenal Insufficiency, ChronicRisk FactorsSex FactorsTransferrinBiomarkersFerritinsHemoglobinsIronTransferrin

Identifiers

PMID24586229
PMCPMC3929276
OpenAlexW2082958329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.